Your browser doesn't support javascript.
loading
Opioid Antagonists and the A118G Polymorphism in the µ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen, Hisham; Nestor, Liam J; Subramaniam, Naresh; Dodds, Chris; Nathan, Pradeep J; Miller, Sam R; Sarai, Bhopinder K; Maltby, Kay; Fernando, Disala; Warren, Liling; Hosking, Louise K; Waterworth, Dawn; Korzeniowska, Anna; Win, Beta; Richards, Duncan B; Vasist Johnson, Lakshmi; Fletcher, Paul C; Bullmore, Edward T.
Afiliação
  • Ziauddeen H; Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Nestor LJ; Wellcome Trust MRC Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
  • Subramaniam N; Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn Hospital, Cambridge, UK.
  • Dodds C; Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Nathan PJ; Centre for Neuropsychopharmacology, Imperial College, London, UK.
  • Miller SR; Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Sarai BK; Wellcome Trust MRC Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
  • Maltby K; Department of Psychology, University of Exeter, Exeter, UK.
  • Fernando D; Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Warren L; Neuroscience Center of Excellence, inVentiv Health Clinical, Maidenhead, UK.
  • Hosking LK; School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.
  • Waterworth D; GSK Medicines Research Centre, Stevenage, UK.
  • Korzeniowska A; Medimmune, Granta Park, Cambridge, UK.
  • Win B; GSK Clinical Unit, Cambridge Biomedical Campus, Cambridge, UK.
  • Richards DB; GSK Clinical Unit, Cambridge Biomedical Campus, Cambridge, UK.
  • Vasist Johnson L; Acclarogen, St John's Innovation Centre, Cambridge, UK.
  • Fletcher PC; GSK Medicines Research Centre, Stevenage, UK.
  • Bullmore ET; Genetics, Target Science, GlaxoSmithKline, King of Prussia, PA, USA.
Neuropsychopharmacology ; 41(11): 2647-57, 2016 10.
Article em En | MEDLINE | ID: mdl-27109624
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Receptores Opioides mu / Polimorfismo de Nucleotídeo Único / Ingestão de Líquidos / Indanos / Naltrexona / Antagonistas de Entorpecentes Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Receptores Opioides mu / Polimorfismo de Nucleotídeo Único / Ingestão de Líquidos / Indanos / Naltrexona / Antagonistas de Entorpecentes Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article